NASDAQ · Analyst Forecast

Wave Life Sciences, Inc. (WVE) Stock Forecast & Price Target

$2.84 NASDAQ: WVE Market Cap $560.13M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Wave Life Sciences, Inc. (WVE), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Wave Life Sciences, Inc., analysts forecast revenue rising from $41.01M in 2025 to $361.74M in 2030; the average estimate for 2030 earnings per share is −$0.32; with published estimates ranging from −$0.44 to −$0.25; 18 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$2.84
Consensus targetThe average of the price targets analysts have published.$12.33
Median targetThe middle target, less affected by a single outlier.$13.00
Highest targetThe most optimistic published target.$14.00
Lowest targetThe most pessimistic published target.$10.00
Difference from priceHow far the consensus target sits from today’s price.+334.2%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$36.28M$41.01M$46.05M11
2026$57.51M$63.63M$70.92M15
2027$28.28M$38.96M$62.36M15
2028$44.10M$52.91M$67.96M18
2029$113.84M$136.56M$175.41M13
2030$301.55M$361.74M$464.64M13

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$1.28−$1.19−$1.1011
2026−$1.18−$1.11−$0.8815
2027−$1.87−$1.29−$0.4715
2028−$1.88−$1.29−$0.2818
2029−$1.48−$1.08−$0.8513
2030−$0.44−$0.32−$0.2513

Wave Life Sciences, Inc. (WVE) forecast — frequently asked questions

What is the analyst price target for Wave Life Sciences, Inc.?

Analysts covering Wave Life Sciences, Inc. (WVE) have a consensus price target of $12.33, 334.2% above the current price of $2.84. Published targets range from $10.00 to $14.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Wave Life Sciences, Inc.'s earnings?

The average analyst estimate for Wave Life Sciences, Inc. (WVE) earnings per share in 2030 is -0.32, with individual estimates between -0.44 and -0.25.

How much revenue is Wave Life Sciences, Inc. expected to make?

Analysts forecast Wave Life Sciences, Inc. (WVE) revenue of $361.74M in 2030, based on 13 published estimates.

How many analysts cover WVE?

18 analysts contribute estimates for Wave Life Sciences, Inc. (WVE). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.